Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
- PMID: 14600205
- DOI: 10.1093/protein/gzg096
Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
Abstract
A prerequisite for the enrichment of antibodies screened from phage display libraries is their stable expression on a phage during multiple selection rounds. Thus, if stringent panning procedures are employed, selection is simultaneously driven by antigen affinity, stability and solubility. To take advantage of robust pre-selected scaffolds of such molecules, we grafted single-chain Fv (scFv) antibodies, previously isolated from a human phage display library after multiple rounds of in vitro panning on tumor cells, with the specificity of the clinically established murine monoclonal anti-CD22 antibody RFB4. We show that a panel of grafted scFvs retained the specificity of the murine monoclonal antibody, bound to the target antigen with high affinity (6.4-9.6 nM), and exhibited exceptional biophysical stability with retention of 89-93% of the initial binding activity after 6 days of incubation in human serum at 37 degrees C. Selection of stable human scaffolds with high sequence identity to both the human germline and the rodent frameworks required only a small number of murine residues to be retained within the human frameworks in order to maintain the structural integrity of the antigen binding site. We expect this approach may be applicable for the rapid generation of highly stable humanized antibodies with low immunogenic potential.
Similar articles
-
Generation of a highly stable, internalizing anti-CD22 single-chain Fv fragment for targeting non-Hodgkin's lymphoma.Int J Cancer. 2003 Dec 10;107(5):822-9. doi: 10.1002/ijc.11451. Int J Cancer. 2003. PMID: 14566834
-
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin.J Biol Chem. 2005 Jan 7;280(1):607-17. doi: 10.1074/jbc.M409783200. Epub 2004 Oct 18. J Biol Chem. 2005. PMID: 15491997
-
Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.Biochem Biophys Res Commun. 2005 Jun 3;331(2):595-602. doi: 10.1016/j.bbrc.2005.03.215. Biochem Biophys Res Commun. 2005. PMID: 15850802
-
Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning.Antibodies (Basel). 2017 Aug 5;6(3):10. doi: 10.3390/antib6030010. Antibodies (Basel). 2017. PMID: 31548525 Free PMC article. Review.
-
Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains.Curr Drug Discov Technol. 2014 Mar;11(1):28-40. doi: 10.2174/15701638113109990032. Curr Drug Discov Technol. 2014. PMID: 23863097 Free PMC article. Review.
Cited by
-
Directed evolution methods for overcoming trade-offs between protein activity and stability.AIChE J. 2020 Mar;66(3):e16814. doi: 10.1002/aic.16814. Epub 2019 Oct 9. AIChE J. 2020. PMID: 32719568 Free PMC article.
-
Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.Biomedicines. 2017 Jun 2;5(2):28. doi: 10.3390/biomedicines5020028. Biomedicines. 2017. PMID: 28574434 Free PMC article. Review.
-
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.MAbs. 2009 Mar-Apr;1(2):128-41. doi: 10.4161/mabs.1.2.7631. Epub 2009 Mar 11. MAbs. 2009. PMID: 20061822 Free PMC article.
-
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus.PLoS One. 2009 Aug 13;4(8):e6625. doi: 10.1371/journal.pone.0006625. PLoS One. 2009. PMID: 19675673 Free PMC article.
-
Antibody Fragments as Probe in Biosensor Development.Sensors (Basel). 2008 Aug 8;8(8):4669-4686. doi: 10.3390/s8084669. Sensors (Basel). 2008. PMID: 27873779 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources